KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OR Royalties (OR) EBT (2016 - 2025)

Historic EBT for Royalties (OR) over the last 11 years, with Q3 2025 value amounting to $92.1 million.

  • Royalties' EBT rose 37968.95% to $92.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $181.0 million, marking a year-over-year increase of 62640.09%. This contributed to the annual value of $30.1 million for FY2024, which is 20906.39% up from last year.
  • According to the latest figures from Q3 2025, Royalties' EBT is $92.1 million, which was up 37968.95% from $39.4 million recorded in Q2 2025.
  • Royalties' 5-year EBT high stood at $92.1 million for Q3 2025, and its period low was -$48.5 million during Q4 2023.
  • For the 5-year period, Royalties' EBT averaged around $14.5 million, with its median value being $18.9 million (2022).
  • The largest annual percentage gain for Royalties' EBT in the last 5 years was 1305088.75% (2023), contrasted with its biggest fall of 35726.2% (2023).
  • Quarter analysis of 5 years shows Royalties' EBT stood at $22.8 million in 2021, then dropped by 17.24% to $18.9 million in 2022, then crashed by 357.26% to -$48.5 million in 2023, then surged by 132.92% to $16.0 million in 2024, then soared by 476.11% to $92.1 million in 2025.
  • Its EBT was $92.1 million in Q3 2025, compared to $39.4 million in Q2 2025 and $33.5 million in Q1 2025.